nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—Carboplatin—esophageal cancer	0.45	0.539	CbGbCtD
Propylthiouracil—MPO—Cisplatin—esophageal cancer	0.384	0.461	CbGbCtD
Propylthiouracil—TPO—neck—esophageal cancer	0.011	0.272	CbGeAlD
Propylthiouracil—DIO1—lung—esophageal cancer	0.0106	0.261	CbGeAlD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—MXI1—esophageal cancer	0.0105	0.107	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.00625	0.0641	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.00625	0.0641	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—NFE2L2—esophageal cancer	0.00593	0.0608	CbGpPWpGaD
Propylthiouracil—TPO—digestive system—esophageal cancer	0.0057	0.141	CbGeAlD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—RUNX1—esophageal cancer	0.0055	0.0564	CbGpPWpGaD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF3—esophageal cancer	0.00495	0.0507	CbGpPWpGaD
Propylthiouracil—DBH—digestive system—esophageal cancer	0.00372	0.0918	CbGeAlD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.00293	0.03	CbGpPWpGaD
Propylthiouracil—MPO—epithelium—esophageal cancer	0.00261	0.0645	CbGeAlD
Propylthiouracil—MPO—C-MYB transcription factor network—CA1—esophageal cancer	0.00234	0.0239	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.00225	0.0231	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.00225	0.0231	CbGpPWpGaD
Propylthiouracil—DBH—lymph node—esophageal cancer	0.00212	0.0524	CbGeAlD
Propylthiouracil—DIO1—Selenium Micronutrient Network—SOD2—esophageal cancer	0.002	0.0205	CbGpPWpGaD
Propylthiouracil—MPO—digestive system—esophageal cancer	0.00199	0.0491	CbGeAlD
Propylthiouracil—Pigmentation disorder—Capecitabine—esophageal cancer	0.00176	0.0628	CcSEcCtD
Propylthiouracil—MPO—lung—esophageal cancer	0.00166	0.041	CbGeAlD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—esophageal cancer	0.00163	0.0167	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.00157	0.0161	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.00157	0.0161	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—NOTCH1—esophageal cancer	0.00141	0.0144	CbGpPWpGaD
Propylthiouracil—Allergic cutaneous angiitis—Methotrexate—esophageal cancer	0.00137	0.0491	CcSEcCtD
Propylthiouracil—MPO—lymph node—esophageal cancer	0.00114	0.028	CbGeAlD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.00112	0.0115	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—SOD2—esophageal cancer	0.00111	0.0114	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—NOS2—esophageal cancer	0.0011	0.0113	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.00105	0.0108	CbGpPWpGaD
Propylthiouracil—Ageusia—Cisplatin—esophageal cancer	0.000983	0.0351	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.00096	0.00984	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.00096	0.00984	CbGpPWpGaD
Propylthiouracil—Liver injury—Cisplatin—esophageal cancer	0.000947	0.0338	CcSEcCtD
Propylthiouracil—Lung infiltration—Methotrexate—esophageal cancer	0.000932	0.0333	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—SOD2—esophageal cancer	0.000905	0.00927	CbGpPWpGaD
Propylthiouracil—Interstitial pneumonia—Methotrexate—esophageal cancer	0.000905	0.0323	CcSEcCtD
Propylthiouracil—TPO—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.000902	0.00925	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.000902	0.00925	CbGpPWpGaD
Propylthiouracil—Leukocytoclastic vasculitis—Methotrexate—esophageal cancer	0.000891	0.0318	CcSEcCtD
Propylthiouracil—Body temperature increased—Carboplatin—esophageal cancer	0.000766	0.0274	CcSEcCtD
Propylthiouracil—Skin ulcer—Capecitabine—esophageal cancer	0.000754	0.0269	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SLC52A3—esophageal cancer	0.000735	0.00754	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—BLVRB—esophageal cancer	0.000735	0.00754	CbGpPWpGaD
Propylthiouracil—Ageusia—Capecitabine—esophageal cancer	0.000725	0.0259	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000719	0.00737	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Cisplatin—esophageal cancer	0.000626	0.0224	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CA1—esophageal cancer	0.000625	0.00641	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC10A2—esophageal cancer	0.000625	0.00641	CbGpPWpGaD
Propylthiouracil—Interstitial lung disease—Methotrexate—esophageal cancer	0.000618	0.0221	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CA2—esophageal cancer	0.000572	0.00586	CbGpPWpGaD
Propylthiouracil—Skin ulcer—Methotrexate—esophageal cancer	0.000562	0.0201	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PLCE1—esophageal cancer	0.000532	0.00545	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ADH7—esophageal cancer	0.000532	0.00545	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CREBBP—esophageal cancer	0.000512	0.00524	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—esophageal cancer	0.000497	0.00509	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Capecitabine—esophageal cancer	0.000474	0.0169	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ADH1B—esophageal cancer	0.000466	0.00478	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Capecitabine—esophageal cancer	0.000462	0.0165	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000452	0.0161	CcSEcCtD
Propylthiouracil—DBH—Metabolism—BLVRB—esophageal cancer	0.000449	0.0046	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC52A3—esophageal cancer	0.000449	0.0046	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000448	0.00459	CbGpPWpGaD
Propylthiouracil—Vasculitis—Methotrexate—esophageal cancer	0.000448	0.016	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—TYMP—esophageal cancer	0.000445	0.00457	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—BCL2—esophageal cancer	0.000441	0.00452	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000437	0.0156	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP26A1—esophageal cancer	0.000433	0.00444	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALOX15—esophageal cancer	0.000422	0.00433	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC52A3—esophageal cancer	0.000422	0.00433	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—BLVRB—esophageal cancer	0.000422	0.00433	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—PTGS2—esophageal cancer	0.000419	0.00429	CbGpPWpGaD
Propylthiouracil—Aplastic anaemia—Methotrexate—esophageal cancer	0.00041	0.0147	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000404	0.00414	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—TPI1—esophageal cancer	0.000403	0.00413	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTO1—esophageal cancer	0.000403	0.00413	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALDOB—esophageal cancer	0.000386	0.00396	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CA1—esophageal cancer	0.000382	0.00391	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC10A2—esophageal cancer	0.000382	0.00391	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—esophageal cancer	0.000379	0.00388	CbGpPWpGaD
Propylthiouracil—Lymphadenopathy—Methotrexate—esophageal cancer	0.000372	0.0133	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GAPDH—esophageal cancer	0.000372	0.00381	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CRABP1—esophageal cancer	0.000368	0.00378	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1A—esophageal cancer	0.000366	0.00375	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CA1—esophageal cancer	0.000359	0.00368	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC10A2—esophageal cancer	0.000359	0.00368	CbGpPWpGaD
Propylthiouracil—Alopecia—Cisplatin—esophageal cancer	0.000354	0.0126	CcSEcCtD
Propylthiouracil—Hepatic failure—Methotrexate—esophageal cancer	0.000353	0.0126	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GNG7—esophageal cancer	0.00035	0.00359	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CA2—esophageal cancer	0.000349	0.00358	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—EP300—esophageal cancer	0.000348	0.00357	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Methotrexate—esophageal cancer	0.000344	0.0123	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000336	0.012	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ALDH2—esophageal cancer	0.000328	0.00337	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CA2—esophageal cancer	0.000328	0.00337	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ADH7—esophageal cancer	0.000325	0.00333	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PLCE1—esophageal cancer	0.000325	0.00333	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000322	0.0115	CcSEcCtD
Propylthiouracil—Jaundice—Capecitabine—esophageal cancer	0.00032	0.0114	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTT1—esophageal cancer	0.000312	0.0032	CbGpPWpGaD
Propylthiouracil—Leukopenia—Cisplatin—esophageal cancer	0.000312	0.0111	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP2A6—esophageal cancer	0.000309	0.00317	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Capecitabine—esophageal cancer	0.000307	0.011	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PLCE1—esophageal cancer	0.000305	0.00313	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ADH7—esophageal cancer	0.000305	0.00313	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—esophageal cancer	0.000304	0.00311	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—esophageal cancer	0.000302	0.0031	CbGpPWpGaD
Propylthiouracil—Myalgia—Cisplatin—esophageal cancer	0.000296	0.0106	CcSEcCtD
Propylthiouracil—Haemoglobin—Capecitabine—esophageal cancer	0.000296	0.0106	CcSEcCtD
Propylthiouracil—Haemorrhage—Capecitabine—esophageal cancer	0.000295	0.0105	CcSEcCtD
Propylthiouracil—Hepatitis—Capecitabine—esophageal cancer	0.000295	0.0105	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PTGS1—esophageal cancer	0.000293	0.003	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ENO1—esophageal cancer	0.000293	0.003	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PSME2—esophageal cancer	0.000288	0.00296	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PSME1—esophageal cancer	0.000288	0.00296	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ADH1B—esophageal cancer	0.000285	0.00292	CbGpPWpGaD
Propylthiouracil—Oedema—Cisplatin—esophageal cancer	0.000284	0.0102	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Cisplatin—esophageal cancer	0.000278	0.00994	CcSEcCtD
Propylthiouracil—DBH—Metabolism—TYMP—esophageal cancer	0.000272	0.00279	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ADH1B—esophageal cancer	0.000268	0.00274	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP26A1—esophageal cancer	0.000265	0.00271	CbGpPWpGaD
Propylthiouracil—Alopecia—Capecitabine—esophageal cancer	0.000261	0.00931	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000259	0.00925	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ALOX15—esophageal cancer	0.000258	0.00264	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TYMP—esophageal cancer	0.000256	0.00262	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Cisplatin—esophageal cancer	0.000255	0.00912	CcSEcCtD
Propylthiouracil—Dysgeusia—Capecitabine—esophageal cancer	0.000251	0.00898	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP1B1—esophageal cancer	0.000249	0.00255	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP26A1—esophageal cancer	0.000249	0.00255	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTO1—esophageal cancer	0.000246	0.00252	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TPI1—esophageal cancer	0.000246	0.00252	CbGpPWpGaD
Propylthiouracil—Drowsiness—Methotrexate—esophageal cancer	0.000245	0.00874	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ALOX15—esophageal cancer	0.000243	0.00249	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALDOB—esophageal cancer	0.000236	0.00242	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP19A1—esophageal cancer	0.000234	0.0024	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTO1—esophageal cancer	0.000231	0.00237	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TPI1—esophageal cancer	0.000231	0.00237	CbGpPWpGaD
Propylthiouracil—Vertigo—Capecitabine—esophageal cancer	0.000231	0.00824	CcSEcCtD
Propylthiouracil—Leukopenia—Capecitabine—esophageal cancer	0.00023	0.00821	CcSEcCtD
Propylthiouracil—Agranulocytosis—Methotrexate—esophageal cancer	0.000228	0.00815	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GAPDH—esophageal cancer	0.000227	0.00233	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CRABP1—esophageal cancer	0.000225	0.00231	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Cisplatin—esophageal cancer	0.000225	0.00803	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ALDOB—esophageal cancer	0.000222	0.00227	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Methotrexate—esophageal cancer	0.000221	0.00788	CcSEcCtD
Propylthiouracil—Haemorrhage—Methotrexate—esophageal cancer	0.00022	0.00784	CcSEcCtD
Propylthiouracil—Hepatitis—Methotrexate—esophageal cancer	0.00022	0.00784	CcSEcCtD
Propylthiouracil—Arthralgia—Capecitabine—esophageal cancer	0.000219	0.00781	CcSEcCtD
Propylthiouracil—Myalgia—Capecitabine—esophageal cancer	0.000219	0.00781	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GNG7—esophageal cancer	0.000214	0.00219	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GAPDH—esophageal cancer	0.000214	0.00219	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HMOX1—esophageal cancer	0.000214	0.00219	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CRABP1—esophageal cancer	0.000212	0.00217	CbGpPWpGaD
Propylthiouracil—Oedema—Capecitabine—esophageal cancer	0.00021	0.00748	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Capecitabine—esophageal cancer	0.000205	0.00733	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ABCB1—esophageal cancer	0.000205	0.0021	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GNG7—esophageal cancer	0.000201	0.00206	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALDH2—esophageal cancer	0.000201	0.00206	CbGpPWpGaD
Propylthiouracil—Alopecia—Methotrexate—esophageal cancer	0.000194	0.00693	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000191	0.00682	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTT1—esophageal cancer	0.000191	0.00196	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP2A6—esophageal cancer	0.000189	0.00193	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALDH2—esophageal cancer	0.000189	0.00193	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Capecitabine—esophageal cancer	0.000188	0.00672	CcSEcCtD
Propylthiouracil—Dysgeusia—Methotrexate—esophageal cancer	0.000187	0.00669	CcSEcCtD
Propylthiouracil—Dyspepsia—Capecitabine—esophageal cancer	0.000184	0.00659	CcSEcCtD
Propylthiouracil—Vomiting—Cisplatin—esophageal cancer	0.000181	0.00646	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTT1—esophageal cancer	0.000179	0.00184	CbGpPWpGaD
Propylthiouracil—Rash—Cisplatin—esophageal cancer	0.000179	0.0064	CcSEcCtD
Propylthiouracil—Dermatitis—Cisplatin—esophageal cancer	0.000179	0.0064	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PTGS1—esophageal cancer	0.000179	0.00183	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ENO1—esophageal cancer	0.000179	0.00183	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2A6—esophageal cancer	0.000177	0.00182	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PSME2—esophageal cancer	0.000176	0.00181	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PSME1—esophageal cancer	0.000176	0.00181	CbGpPWpGaD
Propylthiouracil—Vertigo—Methotrexate—esophageal cancer	0.000172	0.00613	CcSEcCtD
Propylthiouracil—Leukopenia—Methotrexate—esophageal cancer	0.000171	0.00611	CcSEcCtD
Propylthiouracil—Nausea—Cisplatin—esophageal cancer	0.000169	0.00603	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ENO1—esophageal cancer	0.000168	0.00172	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS1—esophageal cancer	0.000168	0.00172	CbGpPWpGaD
Propylthiouracil—Urticaria—Capecitabine—esophageal cancer	0.000166	0.00595	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PSME1—esophageal cancer	0.000166	0.0017	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PSME2—esophageal cancer	0.000166	0.0017	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Capecitabine—esophageal cancer	0.000166	0.00592	CcSEcCtD
Propylthiouracil—Arthralgia—Methotrexate—esophageal cancer	0.000163	0.00581	CcSEcCtD
Propylthiouracil—Myalgia—Methotrexate—esophageal cancer	0.000163	0.00581	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Methotrexate—esophageal cancer	0.000153	0.00546	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP1B1—esophageal cancer	0.000152	0.00156	CbGpPWpGaD
Propylthiouracil—Pruritus—Capecitabine—esophageal cancer	0.000148	0.0053	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP19A1—esophageal cancer	0.000143	0.00147	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1B1—esophageal cancer	0.000143	0.00147	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000142	0.00508	CcSEcCtD
Propylthiouracil—Paraesthesia—Methotrexate—esophageal cancer	0.00014	0.005	CcSEcCtD
Propylthiouracil—Somnolence—Methotrexate—esophageal cancer	0.000139	0.00495	CcSEcCtD
Propylthiouracil—Dyspepsia—Methotrexate—esophageal cancer	0.000137	0.0049	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CREBBP—esophageal cancer	0.000137	0.0014	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP19A1—esophageal cancer	0.000134	0.00138	CbGpPWpGaD
Propylthiouracil—Vomiting—Capecitabine—esophageal cancer	0.000133	0.00476	CcSEcCtD
Propylthiouracil—Rash—Capecitabine—esophageal cancer	0.000132	0.00472	CcSEcCtD
Propylthiouracil—Dermatitis—Capecitabine—esophageal cancer	0.000132	0.00471	CcSEcCtD
Propylthiouracil—Headache—Capecitabine—esophageal cancer	0.000131	0.00469	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HMOX1—esophageal cancer	0.00013	0.00134	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCB1—esophageal cancer	0.000125	0.00128	CbGpPWpGaD
Propylthiouracil—Nausea—Capecitabine—esophageal cancer	0.000124	0.00445	CcSEcCtD
Propylthiouracil—Urticaria—Methotrexate—esophageal cancer	0.000124	0.00443	CcSEcCtD
Propylthiouracil—Body temperature increased—Methotrexate—esophageal cancer	0.000123	0.0044	CcSEcCtD
Propylthiouracil—TPO—Metabolism—HMOX1—esophageal cancer	0.000123	0.00126	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NOS3—esophageal cancer	0.000123	0.00126	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCB1—esophageal cancer	0.000118	0.00121	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTGS2—esophageal cancer	0.000112	0.00115	CbGpPWpGaD
Propylthiouracil—Pruritus—Methotrexate—esophageal cancer	0.00011	0.00394	CcSEcCtD
Propylthiouracil—Vomiting—Methotrexate—esophageal cancer	9.92e-05	0.00354	CcSEcCtD
Propylthiouracil—Rash—Methotrexate—esophageal cancer	9.83e-05	0.00351	CcSEcCtD
Propylthiouracil—Dermatitis—Methotrexate—esophageal cancer	9.82e-05	0.00351	CcSEcCtD
Propylthiouracil—Headache—Methotrexate—esophageal cancer	9.77e-05	0.00349	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—EP300—esophageal cancer	9.33e-05	0.000956	CbGpPWpGaD
Propylthiouracil—Nausea—Methotrexate—esophageal cancer	9.26e-05	0.00331	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CREBBP—esophageal cancer	8.37e-05	0.000858	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CREBBP—esophageal cancer	7.87e-05	0.000806	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NOS3—esophageal cancer	7.49e-05	0.000768	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NOS3—esophageal cancer	7.04e-05	0.000722	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—esophageal cancer	6.9e-05	0.000707	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTGS2—esophageal cancer	6.85e-05	0.000702	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS2—esophageal cancer	6.44e-05	0.00066	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—EP300—esophageal cancer	5.7e-05	0.000584	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—EP300—esophageal cancer	5.36e-05	0.000549	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—esophageal cancer	4.22e-05	0.000432	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—esophageal cancer	3.96e-05	0.000406	CbGpPWpGaD
